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In humans, pregnancy may be interrupted at various stages, leading to abortion, and this process occurs repetitively in 
some patients. Repetitive interruptions of pregnancy are vari-
ously referred to as recurrent spontaneous abortion (RSA), 
recurrent pregnancy loss (RPL), recurrent miscarriage (RM), 
idiopathic recurrent miscarriage (iRM), or unexplained 
recurrent spontaneous abortion (URSA). These different 
terms indicate terminations of pregnancy occurring more 
than 2 times before 24 weeks of gestation, in most defini-
tions of the syndrome. In humans, it appears that at least 
15% of the recognized pregnancies end in miscarriage. In 
an estimated half of the cases, chromosomal anomalies such 
as aneuploidies are observed.[1]
In this review, we will attempt to summarize current 
knowledge on the genetic basis of recurrent abortions, and 
will not deal with environmental or stochastic factors that 
can lead to isolated abortive events. Clearly, for instance, 
the increase of chromosomal anomalies leading to aneu-
ploidy and mosaicism in blastocyst[2] is generally associated 
with motherÊs age (even though paternal age may also be 
considered as a risk factor)[3] and is beyond the scope of 
the present review. However, genetic defects leading to a 
quasi-systematic increase of aneuploidy will be considered. 
Other possible genetic causes of recurrent abortion may 
be found in developmental defects of the blastocyst or the 
embryo that do not involve gross chromosome anomalies, 
but probably much more frequently involve a defective 
materno-fetal immunological dialog, or a defective uterine 
function impeding early development. There is a plethora 
of articles dealing with genetic polymorphisms associated 
with RSA. However, until now, the genetic polymorphism 
analysis has been concentrated on a limited number of genes. 
We will not attempt to review exhaustively the existing lit-
erature, which analyzes various populations worldwide, but 
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Recurrent pregnancy loss, defined as a pregnancy failure occurring 
before 24 weeks of gestation more than two or three times according to 
most definitions, is a fertility defect encountered in 1-5% of the patients. 
This defect is of course of multifactorial origin. Among the possible 
origins of recurrent pregnancy loss are uterine structural defaults, 
defective ploidy control of the embryo, defective immunological 
dialog between the embryo (or the fetus) and the uterus sometimes in 
relation with immunological disorders (such as autoimmune diseases), 
thrombophilia, and free radical metabolism imbalance. Numerous studies 
attempted to correlate variants of genes supposed to be intervening in 
the different facets of the early maternalăfetal or maternalăembryonic 
dialog, and eventually modify the outcome of fertilization, leading to 
success or failure of post-implantation development. The objective of 
the present review is to portray the major genes and gene polymorphisms studied for their putative 
association with recurrent pregnancy loss. Most of these genes have been studied as candidate genes 
for which strong biological arguments were put forward as to their putative involvement in recurrent 
pregnancy loss. They were mostly studied by genetic analysis, often in various populations of different 
ethnic origins, throughout the world. Some of these studies were available only in English as abstracts 
and were nevertheless used if the information was given with enough detail. With the space being too 
short to depict all the available literature, different major pathways relevant to the scientific question 
are presented without any attempt to hide the fact that discordant views often aroused for a given gene.
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rather attempt to categorize the factors that were analyzed 
according to their biological functions and summarize their 
putative effects.
Candidate gene approaches
Feto-placental side
Genetic bases of defective chromosome content or 
structure
In a biological sense, genetic defects leading to abor-
tion may originate from two partners: The conceptus and the 
uterus. From the conceptus side, it is well-established that 
chromosomal anomalies lead to implantation defects. How-
ever, they occur mostly stochastically; to be the genetic cause 
of a recurrent loss, a genetic defect leading to systematic 
chromosome anomalies has to be found, as nicely reviewed 
recently by Kurahashi and coworkers.[4] Abnormal chromo-
some structure may originate from defects in the checkpoint 
mechanisms that constitute a quality control factory of the 
cell, which is able to detect meiosis anomalies and is called 
Spindle Assembly Checkpoint (SAC), constituted by pro-
teins such as Mad1, Mad2, Bub1, Bub3, BubR1, and Mps1.[5] 
A very recent study addressed this question on the general 
issue of defective reproduction performance, by screen-
ing two candidate genes, aurora kinase B (AURKB) and 
synaptonemal complex protein 3 (SYCP3). In the AURKB 
gene, the authors identified low-frequency (0.5%) non-syn-
onymous variants (c. 155C.T, c. 236T.C, and c. 880G.A) 
inducing the changes p.A52V, p.I79T, and p.A294T in the 
polypeptidic chain, respectively. 236T >C and 880G >A 
were associated with antecedents of pregnancy losses.[6] 
This preliminary study is one of those that pave the way 
toward evaluating genes playing a role in the quality of the 
meiotic progression. Two other genes have been investigated 
to this respect in miscarriage, BUB1 and MAD2.[7] The 
authors showed firstly that as generally assumed, half the 
embryos from spontaneous miscarriages have an abnormal 
karyotype. By western blotting, the authors quantified the 
two proteins and estimated that they were under-expressed 
in pathological cases. The authors also isolated chorionic 
villi where they targeted BUB1 and MAD2 expression by 
short hairpin RNA (shRNA) and showed that this induces 
an abnormal karyotype at a ~ sixfold increased frequency, 
compared to controls (indicating that mitotic defects can 
also be induced when these genes are dysfunctional). The 
role of MAD2 in such defects was independently confirmed 
by another study on trisomic abortuses.[8] Clearly, therefore, 
anomalies in spindle assembly can lead to aneuploidies, and 
infertilities in the most severe cases, such as in the case of the 
recently identified mutation of the cohesin STAG3, leading 
to premature ovarian failure,[9] but less severe mutations in 
the SAC genes could lead to variants that have more subtle 
effects. There is clearly space for studying this aspect of 
spindle stability on a wider basis than what has been per-
formed up to now in the context of recurrent miscarriage.
Placental developmental defects
The mammalian placenta plays several crucial roles 
in the initiation and maintenance of pregnancy. In humans, 
it constitutes the main immunological interface between 
mother and child, allowing tolerance between two geneti-
cally distinct organisms. It is the major exchange surface 
between the two; at the end of pregnancy, 600 ml of mater-
nal blood circulates through the placenta at each minute. 
Finally, it secretes important hormones such as the human 
chorionic gonadotrophin (hCG) and the human placental lac-
togen (hPL) that have immunotrophic functions. In humans, 
the functional unit of the placenta is the placental villus, a 
densely branched tree (up to 16 ramification levels), covered 
by a syncytium, the syncytiotrophoblast.[10] Normally, there 
is an intimate relation between the endometrium and the 
invasive human placenta; therefore, it can be suspected that 
at least in some cases, defective invasion can be caused by 
genetic specificities of the placenta and may lead to abortion.
In a recent study of Lyu and coworkers,[11] the authors 
investigated the placental villi in the cases of idiopathic 
miscarriages, comparing four controls and four miscar-
riages with expression microarrays, after collecting the 
villi at 10-12 weeks. In this study, the authors uncovered 
essentially modifications in the management of oxidative 
stress, and more specifically, in glutathione metabolism. 
Glutathione depletion leads to accumulation of superoxide 
radicals that play a toxic role in the cells;[12] indeed, gluta-
thione peroxidases are the only enzymes able to manage 
H
2
O
2
 in the mitochondrial context (since catalase is not 
expressed in the mitochondria), and require reduced gluta-
thione (GSH) to convert H
2
O
2
 into water.[13] As well, genes 
involved in mitochondrial function, especially oxidative 
phosphorylation, appeared affected. These results concur 
with several reports linking oxidative stress and recurrent 
miscarriage.[14,15] Consistently, the genetic background of the 
patients was recently explored,[16] and revealed that ABCB1, 
COMT, GPX4, and OGG1 present single-nucleotide poly-
morphisms (SNPs) that are collectively associated with a 
1.97 fold increased risk [confidence interval (CI): 1.31-2.97] 
of recurrent miscarriage. In the latter study, the genes were 
genotyped in the mother, which is responsible for only half 
of the genetic anlagen of the fetus. Nevertheless, it suggests 
that oxidative stress and free radical metabolism defects are 
linked to recurrent abortion.
More and more interest is now shown on the relations 
between oxidative and nitrosative stress in the field of re-
production,[17,18] albeit this issue was apparently not yet sys-
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tematically explored in RSA. One of the important chemical 
intermediates for nitrosative stress is the peroxynitrite ion, 
ONOO−, which results from combining free oxygen species 
with nitric oxide (NO). NO is considered as a major vasodi-
lator molecule, and plays even a crucial role in maintaining 
vascular health, especially in the context of pregnancy.[19] 
NO is produced from l-arginine by NO synthases (NOS). 
Several studies analyzed the polymorphisms of endothelial 
nitric oxide synthase (eNOS) in recurrent pregnancy losses. 
A meta-analysis based upon 18 caseăcontrol studies, pub-
lished in 2011,[20] concluded that the Glu298Asp variant of 
eNOS was indeed associated significantly, albeit moderately, 
with RSA [odds ratio (OR): 1.37, CI: 1.11-1.69], this sig-
nificance being observed only when dominant model was 
used. This masks a strong variation in the studies. For the 
present review, we screened 10 studies on eNOS published 
from 2001 to 2011, but focusing sometimes on polymor-
phisms other than Glu298Asp. Five studies concluded to 
an effect,[21-25] while five concluded to no effect.[26-30] It is 
well known that such discrepancies frequently occur in as-
sociation studies, and clearly, meta-analysis cannot always 
substitute well-conducted experimental analyses with a 
sufficient statistical power.[31] To explain the differences 
observed in the case of eNOS (but it applies equally well 
to other polymorphisms), one possibility could be related 
to the geographic origin of the various studies: Amongst the 
five positive ones, two are from India, one from Korea, one 
from China, and only one concerns a Caucasian popula-
tion (Austria[21]). By contrast, the five negative studies are 
from Greece, Tunisia, Japan, Germany, and Austria and 
are, therefore, composed of Caucasian populations except 
the Japanese study. In the 10 studies that we screened, it is 
also noticeable that on average, the negative studies were 
smaller (cases 174 μ 104, controls 120 μ 53) than the posi-
tive ones (cases 186 μ 93, controls 169 μ 84), which may 
contribute to losing detection power.
Maternal side
Hyperimmune reactivity
The idea of the existence of strong links between im-
munity and reproduction is old, and nurtured by the fact 
that the fetus expresses paternal antigens that should be the 
target of graft-rejection mechanisms. Several theories have 
been proposed to explain the mere biological possibility of 
the pregnancy.[32,33] The links between major histocompat-
ibility complex (MHC) haplotypes and graft rejection has 
been clearly established long ago.[34]
Autoimmune diseases
The presence of autoantibodies is often associated 
with an increased risk of pregnancy loss.[35] This issue 
has been recently extensively reviewed.[36] The group of 
Yehuda Shoenfeld showed a significant increase of several 
autoantibodies in patients with RSA.[37] Amongst other cues 
linking autoimmunity and pregnancy failure, it is interesting 
to quote the work of Mecacci and coworkers that explored 
the links between the detection of thyroid autoantibodies in 
the plasma and RSA. They analyzed a group of 69 patients 
(who were pregnant at least 6 months before the study, 
consisting of 29 RSA, 22 fetal deaths, and 18 preeclamp-
sias), in comparison with a control group of 69 nonpregnant 
women, matched for age, parity, and gravidity. There was 
more than threefold increase in antithyroid autoantibodies 
in RSA patients compared to controls. Results on mice in-
dicate that the detrimental link discovered in these patients 
may be disconnected from a direct action on major relevant 
tissues for pregnancy (such as placenta, decidua, or ovary) 
where the thyroglobulin gene is not strongly expressed.[38]
Once the links between autoimmunity and pregnancy 
failure are established, since this review focuses on genet-
ics, the major issue is to collect relevant information on 
genetic variants leading to an increased risk of autoimmune 
reactions that could influence pregnancy maintenance. One 
exemplary study making this link is provided by a work 
published in 2011 by Salmon and coworkers.[39] In this 
study, a cohort of 250 patients suffering from systemic lupus 
erythematosus (SLE) or expressing antiphospholipid anti-
bodies (APL Ab) was analyzed with respect to genes of the 
complement cascade, since complement modifications have 
recurrently been shown to deregulate the angiogenic balance 
in the placenta.[40] Amongst these patients, 17% suffered 
from preeclampsia (roughly threefold more than expected 
in the general population). While pregnancy loss was not the 
principal topic of the study, there are very strong cues to the 
idea that preeclampsia and pregnancy loss share common 
genetic bases, especially due to alleles increasing the risk of 
thrombophilia (see below).[41,42] In the last study, comparing 
279 thrombophilic patients to 796 control patients, it was 
shown in thrombophilic patients (i.e. harboring risk alleles 
for coagulation factors F5 rs6025 and F2 rs1799963) that 
treatment with low-molecular-weight heparin (LMWH) 
during a new pregnancy attempt decreased the risk of fetal 
death recurrence and preeclampsia simultaneously.
In the Salmon study of 2011, which mainly focused on 
complement factors and preeclampsia, mutations in MCP 
and CFI were found to be increased in patients. The comple-
ment is classically considered to act along two major path-
ways (classical and alternative) [Figure 1]. Both pathways 
induce the hydrolysis of C3 into C3a and C3b. The latter 
cleaves C5 into C5a and C5b, leading eventually to forma-
tion of the membrane attack complex (MAC). Membrane 
cofactor protein (MCP) and complement factor I (CFI) are 
cofactors of the system: MCP is a transmembrane protein 
and CFI is a serine protease able to cleave and inactivate 
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C3b and C4b that are needed for further steps leading to the 
final constitution of the MAC. MCP A304V corresponds 
to a variant displaying 50% reduced activity in the control 
of C3b deposition by the alternative pathway.[43] In addi-
tion, and in direct link to RSA, the authors discovered a 
mutation (K32N) in MCP in an SLE patient with RSA 
and preeclampsia. This mutation induces a 50% decrease 
in C4b binding, compared to wild type. This variant also 
induces a decreased CFI-mediated cleavage activity on C4b. 
MCP, also known as CD46, had been tested in RSA genetic 
studies as early as in 1991[44] using the restriction fragment 
length polymorphism (RFLP) approach. In 1992, a study 
from Finland, using RFLP as well, discovered associations 
between C4 variants and tumor necrosis factor (TNF) vari-
ants with an increased risk of RSA.[45] Since the two genes 
are separated by ~400 kb, it is improbable that the authors 
discovered a mere effect of linkage disequilibrium (LD), 
but rather a process where the two genes are independently 
involved through their specific functions in regulating 
complement/coagulation cascades (case of C4a polymor-
phisms) and inflammation (in the case of TNF). The same 
team published in 1992 a study on 58 RSA couples, which 
did not reveal significant association with TNF variants, 
strengthening the idea of a necessary allelic association 
between C4 and TNF variants to observe a strong pheno-
type.[45] More recent studies carried out in India concur 
with the idea that MCP/CD46 is a genetic risk factor for 
abortion,[46] but again with a limited sample (44 patients). 
A contradictory study was published in 2011 based upon 
a larger population (75 RSA and 115 controls), which 
could not put in evidence an effect of the A304V mutation. 
More recently, a genetic analysis of three complement 
pathway inhibitors, MCP/CD46, CD55, and C4 binding 
protein (C4BP), based on systematic exon sequencing of 
these factors was performed.[47] Overall, 192 patients and 
192 controls were sequenced in this thorough study. A het-
erozygous, non-synonymous mutation was found in C4BPB 
and some others in C4BPA (R240H), previously shown to 
decrease the co-factor activity of C4BP in degrading C3b. 
All the variants of C4BP were studied in vitro to evaluate 
their capacity of modulating the degradation of C3b and 
C4b, showing an important reduction of these biochemical 
capabilities compared to the wild type variant when the 
R120H variant was used, as well as significant effects of 
I126T and I224T.
„Wrong‰ HLA programming
The human MHC system or human leukocyte anti-
gen (HLA) is the „identity card‰ of humans.[48] It is divided 
into three groups of genes on chromosome 6 called Class I 
(HLA-A, -B, -C, -E, -F, -G), Class II (HLA-DP, -DQ, -DR, -
DM, -DO), and Class III (including the TNF and other genes 
encoding proteins involved in inflammatory processes). 
A long time ago, it was shown that the placental structures 
do not present the same MHC molecules than the rest of 
the body[49,50] and that increased homozygosity in moth-
ers lead to pregnancy disorders, supposedly by decreasing 
the chances of allele sharing with the father.[51] As early 
as in 1992, Takakuwa and coworkers analyzed HLA-DQ 
antigens by polymerase chain reaction (PCR)-RFLP. This 
early exploration did not yield significant results,[52] but did 
not discourage further efforts in investigating this issue. In 
fact, the Takakuwa team did later find associations between 
specific DR alleles (DRB1*0403 and DRB1*0410, and 
later DRB1*1502) and DQ alleles with recurrent miscar-
riage.[53] Later on, similar increased risks were associated 
with specific DP alleles, such as DPB1*04.[54,55] By contrast, 
DP alleles appeared not to have a significant effect in the 
study of Sagot and coworkers.[56] In 1992, Christiansen and 
coworkers genotyped DR and DQ by RFLP on 152 patients 
with RSA and 210 controls from Denmark, and concluded 
to a significant effect of specific genotypes such as DRw17, 
DQw2, as well as other specific DQ genotypes.[57-59] Similar 
involvement of the MHC Class II genes was confirmed in 
1993 in the Finnish population.[60] More recent studies in 
Chinese patients suggest that some DQ alleles are risk fac-
tors as well.[61-63] A recent study confirmed the involvement 
of HLA-DR and -DQ variants to be associated with increased 
RSA risk in the Brazilian population.[64] Therefore, the as-
sociation of specific Class II MHC alleles with increased 
miscarriage seems quite robust. Overall, unfortunately, 
mechanistic insights from these abundant genetic/epide-
miological data are absent.
Figure 1: A simplified picture of the two major pathways of the 
complement cascade (the lectin pathway is not represented). In yellow 
boxes are presented the genes that have been analyzed for their putative 
impact on RSA through genotyping populations and that are discussed in 
this review. Interestingly, the polymorphisms that were studied generally 
concern genes having an inhibitory action on the complement cascade.
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For Class I genes, this absence of mechanistic ideas 
on the biological variant function is not totally similar, 
at least for HLA-G, referred to as an immunosuppressive 
molecule,[65] and for which several polymorphisms were as-
sociated with RSA, as reviewed by Dahl and coworkers.[66] 
HLA-G belongs to the subclass Ib, encompassing HLA-E, 
HLA-F, and HLA-G, and is highly expressed on trophoblast 
cells, which are much less polymorphic than the Class I 
genes [HLA-A and HLA-B are present in all the tissues 
except on the trophoblast cells, while HLA-C is expressed 
at a low level on the trophoblast and has indeed been asso-
ciated with pregnancy disorders, such as preeclampsia and 
miscarriage, depending on the allelic complement of the 
killer cell inhibitory receptor (KIR) harbored by the maternal 
uterine Natural Killer (uNK) cells].[67,68] A very interesting 
feature of HLA-G is that upon specific alternative splicing 
events, the soluble forms HLA-G5, HLA-G6, and HLA-G7 
are released and may play a long-range immunomodulatory 
function. HLA-G is now considered as a reliable marker of 
the success of in vitro fertilization (IVF).[69] In 1997, HLA-G 
was tested to see if it was playing a putative role in the 
materno-fetal immunological dialog, but without taking into 
account any specific polymorphism.[70] In 1999, a consistent 
study evaluating the impact of an intron 4 polymorphism 
was published by Yamashita and coworkers.[71] A non-syn-
onymous substitution in exon 4 did not display significant 
correlations with pregnancy disorders.[72] Nevertheless, the 
situation with regard to HLA-G started to change with a 
study using sophisticated mathematical tools and suggesting 
strongly that further investigation on HLA-G involvement in 
RSA was needed.[73] In 2002, a Scandinavian study focused 
on a 14-bp polymorphism present in the 3′ UTR of the 
gene (generating an Ins/Del in the non-translated 8th exon) 
and found that, curiously, in RSA couples, the 14-bp deletion 
was more abundant in men while the 14-bp insertion was 
more abundant in women.[74] Later, the same team showed 
that the homozygous presence of the 14-bp sequence of exon 
8 in women was significantly associated with infertility, 
combining the risk of unsuccessful IVF treatments and of 
RSA, when the two phenotypes were considered together.[75] 
On the contrary, a study of Indian patients revealed an in-
crease of + 14 bp/î14 bp heterozygotes in RSA women, and 
in another study, some significantly different haplotypes in 
terms of frequency between the two groups of women were 
observed.[76] In a more recent article, paternal lymphocyte 
alloimmunization therapy (PLAT) was positively evaluated 
for treating 42 RSA patients. Thirty-eight became pregnant 
in the following year and 27 babies were born. Interestingly, 
a 100% presence of HLA-G*010401 was seen in the 11 
abortion cases, while it was present in only 51.9% of the 
cases that were a success.[77]  In 2006, a Chinese team could 
not find the association between HLA-G and RSA;[78,79] also, 
a Polish study failed to do so,[80] albeit the team suggested 
that nonsignificance was probably due to the small sample 
size.[81] Two other negative studies were published ă one 
in 2010 that analyzed 143 RSA and 150 control couples 
in the Indian population[82] and another one in 2012 on an 
Iraqi population of 50 RSA and 50 control women.[83] By 
contrast, Xue et al. discovered an excess of heterozygotes 
in Chinese RSA women,[84] while another more recent study 
from China indicated an increased number of +14 bp ho-
mozygotes in the RSA women.[85] Near the 14-bp Ins/Del, 
two polymorphisms (T1570VC and C1594A) were detected 
and found to be associated with RSA risk;[86] T1570C was in 
LD with the cases but not with the controls. Other LD in the 
Class I region were shown.[87] The comprehensive analysis 
of HLA-G sequence in the context of RSA was carried 
out by systematic sequencing of 238 cases and 233 RSA 
in Caucasian women. Twelve SNPs differed between the 
two groups of patients, while the authors also confirmed 
the increased risk brought by the 14-bp insertion.[88] This 
concurred with the results of two Brazilian studies, the first 
one analyzing 60 RSA couples and 60 controls[89] and the 
second one analyzing the outcome of IVF procedures which 
found an increase of allele HLA-G*01:03:01 in the cases of 
implantation failures. This story was interestingly refined in 
2012, with the idea of a sex-dependent increased risk, when 
the mother was + 14 bp/+14 bp homozygote and presented 
with HLA Class II alleles restricting HY immunity. In this 
case, at the second pregnancy in the case of a boy child, 
there was a significant decrease in birth weight and an 
increased risk of miscarriage.[90] Most explanations about 
this influence of the Ins/Del on pregnancy rely on the idea 
of differential stability of the mRNA encoding HLA-G and 
decreasing its concentration. Therefore, HLA-G expression 
level also appears as an important factor, an idea illustrated 
by the study of Ober and coworkers in 2003, associating 
HLA-G polymorphisms and recurrent pregnancy loss 
unambiguously.[91] In this study, the analysis of the novel 
variant -725C/G in the HLA-G promoter uncovered an as-
sociation with miscarriage (OR: 2.76, 95% CI: 1.08-7.09; 
p = 0.035). Interestingly, the G generates a CpG site that is 
methylated, suggesting a possible epigenetic effect in the 
mechanisms of recurrent pregnancy loss, and substanti-
ates the idea of potential impact of DNA methylation in 
reproduction disorders.[92] Recently, and concurrent with 
this idea, more mechanistic experiments were carried out 
on trophoblast from first-trimester placentas of voluntarily 
terminated pregnancies. Immunotolerogenic treatments 
applied to the cells (dexamethasone, hydrocortisone) were 
able to modulate HLA-G expression positively, but the basal 
level of HLA-G was systematically lower in RSA patients.[93]
Since HLA is a relatively small chromosome region 
(<3 Mbp), LD between Class I and Class II can be expected 
and was indeed shown, for instance, in the locus encompass-
ing the three Class II DRB1*03-DQA1*05-DQB1*02,and 
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the Class I G*01010 2. G*010102 is the HLA-G haplotype 
that encompasses the 14-bp sequence variant.[94] This result 
could put forward the idea that only one of these genes is 
actually modulating implantation success, according to the 
alleles displayed by the patient.
A possible member of the dialog between HLA-G (ei-
ther soluble or presented by trophoblasts) and uterine natural 
killer (NK) cells (which are major actors of vasculogenesis 
in pregnancy) is the KIR family. A genetic study showed, 
however, that the KIR repertoire was not different between 
controls and patients, albeit the KIR2DL4 genotypes differed 
significantly (p = 0.03).[95]
Bad adjustments of the cytokinic dialog
Immunity depends strongly on the presence of cir-
culating molecules secreted by the different lymphocyte 
families. An over-simplistic vision of T cells is the idea of 
the existence of a tolerogenic versus aggressive balance, 
materialized as Th1 [inflammatory, secreting, for instance, 
interleukin (IL)-2 and interferon-gamma (INFγ)] and 
Th2 (tolerogenic, secreting, for instance, IL-4, IL-5, IL-6, 
IL-10, and IL-13). Pregnancy was appreciated as a process 
where Th2 lymphocytes were overpowering Th1 lympho-
cytes. This prompted geneticists to find associations between 
cytokine-encoding genes and pregnancy loss.
TH2 pathway
IL-10 polymorphisms were evaluated to this respect 
as early as in 2001,[96] but failed to pinpoint links between 
a G > A polymorphism in the promoter (−1082) and a risk 
of RSA for a population of 38 Finnish patients and 131 
ethnically matched controls. A more systematic study of the 
IL-10 gene promoter analyzed together −592C/A, î819C/T, 
and −1082A/G in strong LD, in 350 RSA cases and 200 con-
trols,[97] showing that the −592A/î819T/î1082A haplotype was 
more frequent in cases than in controls (OR: 4.01, 95% CI: 
1.83-7.95). To note, some negative studies (absence of genetic 
association found) can result from insufficient polymorphism 
of the SNP analyzed. For instance, for IL-10, Warren and co-
workers reported on the comparison between the −1082A/G 
variant and a microsatellite present in the promoter of IL-10, 
and could associate microsatellite alleles but not the SNP to 
cervical insufficiency, a cause of late miscarriage.
IL-6 variants were studied in RSA versus control pa-
tients unsuccessfully in 2003.[98] However, this study was 
contradicted by Saijo and coworkers who discovered a pro-
tector effect of GG genotypes at the −634C-->G promoter 
polymorphism of IL-6 in the Japanese population.[99] This 
association was confirmed in a Chinese sample of 162 RSA 
patients and 156 controls.[100] The same study did not find 
significant differences in IL-1β-31T, -511T, and + 3954T 
between RSA patients and controls.
Interleukin 1 receptor antagonist (IL1RA; an immu-
nomodulator encoded by the ILRN gene) alleles were also 
suggested as at risk for RSA,[101] with strong OR values for 
the effect of a specific allele, *2 (OR: 7.4, CI: 2.9-10.8). 
Consistent with the idea of an effect of this gene, a study 
comparing 37 Finnish women with RSA and 800 donors 
showed an increased frequency of a rare allele (IL1RN*3, 
OR: 5.6, 95% CI: 1.5-19.0; p = 0.006).[102] However, 
negative studies for IL1RN were also reported in various 
populations.[103-105] IL1R1 (the receptor of IL-1 with Th1 
effects) variants were also devoid of significant effects in 
a 2011 study.[106]
Always in the Th2 cascade, Il-4 was unsuccessfully ex-
plored in 2004 in a Japanese population through genotyping 
a specific number of repeat variations in a variable number 
tandem repeat (VNTR) polymorphism.[107]
TH1 pathway
In 2001, Reid and coworkers assessed TNF and IL1B 
alleles as risk factors for RSA, and did find a trend for asso-
ciation with a TNF variant.[108] Il1RB was also studied for an 
exon 5 polymorphism (+3953), while the serum levels were 
followed in parallel in 131 RSA patients and 68 controls, 
and no significant difference could be found.[109] Later, the 
same group studied a C/T polymorphism in the IL1B pro-
moter (−511), together with M235T of AGT (SERPINA8) 
and Glu298Asp of eNOS (NOS3), which was unsuccessful 
again. However, Wang and coworkers identified IL1B -31T 
and IL1B -511C to be associated with a history of RSA[110] 
in two cohorts totaling 262 RPL and 144 controls. This latter 
study also showed that trophoblasts treated by peripheral 
blood mononuclear cells (PBMC) of patients harboring the 
IL1B -511C variant presented an increased INFγ production. 
INFγ genetic polymorphisms may also be directly involved 
as suggested by an Argentine study based upon 41 RSA and 
54 control women. The authors analyzed variants of INFγ, 
TNFα, IL-6, IL-10, and transforming growth factor-be-
ta (TGFβ), and found an association between INFγ 874A→T 
and RSA. Another study analyzed together, though unsuc-
cessfully, the allelic distribution of Il-10 (−1082G > A), 
TNFα (−308G > A), and INFγ (874T > A) alleles in a group 
of 43 patients and 73 controls of Caucasian ethnic back-
ground.[111] TNFα (−308 G/A) was, nevertheless, found to 
be significantly associated with RSA in a sample of Saudi 
women (65 cases vs 65 controls), although the same study 
failed to put forward associations with Il-6 and Il-10 poly-
morphisms.[112]
Amongst the proinflammatory cytokines, Il-21 variants 
were recently evaluated through genotyping a four SNP 
haplotype (rs9992580/rs4833837/rs2055979/rs13143866) 
on 235 RM and 235 controls, and strong risk and protective 
haplotypes could be identified, such as G-A-A-A (OR: 4.02) 
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and T-G-C-G (OR: 0.09), respectively.[113] Since these hap-
lotypes were present in 11.7% of the patients and 18.1% of 
the controls, they are not devoid of clinical interest.
Cytokines and immune cells dialog
Links between interleukin signaling and the immune sys-
tem are numerous. For instance, Il-12 and IL-18 are involved in 
uterine vascular development through the regulation of uterine 
NK cells.[114,115] Promoter gene polymorphisms were analyzed 
for these factors in 125 RSA cases and 136 controls[116] and did 
not demonstrate any significant association. However, a more 
recent study of 282 patients and 283 controls from Saudi Arabia 
on Il-18 promoter haplotypes reconstructed from genotyping 
four SNPs (rs1946519/rs187238/rs360718/rs360717) showed 
several haplotypes associated with reduced IL-18 levels and 
increase RSA risk.[117] A more recent study extended to a Tu-
nisian population the analysis of the same haplotype of four 
SNPs of Il-18 [−656C/A (rs1946519), −137G/C (rs187238), 
−119A/C (rs360718), and −105G/A (rs360717)].[118] A-G-A-A 
and C-G-A-A were associated with an increased risk of 
RPL (OR: 20.73 and 5.23, respectively), and C-G-A-G con-
ferred a protection (OR: 0.29). Overall, these allelic combina-
tions are found in 54% of the controls and 35% of the patients, 
which give them an important potential predictive value.
Contribution of meta-analyses
Overall, meta-analyses may help to clarify the issues 
of the impact of cytokine polymorphism and RSA, such as 
that of Bombell and McGuire,[119] which evaluated studies 
on TNFα, IFNγ, IL1B, Il-6, and IL-10 and concluded that 
IL-1B (−31T, at risk, OR: 2.12, CI: 1.04-4.33, from two 
studies) and IL-6 (−634G, OR: 0.22, 95% CI: 0.09-0.57, but 
from one study only) had significant effects. In 2009, another 
meta-analysis concluded on the effect of the IL-10 geno-
type.[120] A report combining experiments and meta-analyses 
of IL1B and IL1RN VNTR on a sample of Indian women 
did not find the association of variants of these genes with 
RSA.[121] A similar meta-analysis concluded the absence of 
significant effect of IL-6 (rs1800795) and IFNγ (rs2430561), 
but comforted the idea of an association of IL-10 −1082A/G 
with the risk of RSA (rs1800896).
Thrombophilic disorders
There is an interesting and well-documented literature 
on the links between pregnancy loss and vascular diseases 
of pregnancy, particularly preeclampsia. Preeclampsia is a 
major disease of pregnancy, characterized by a gestational 
increase of maternal blood pressure and proteinuria.[122,123] 
The etiology of preeclampsia remains largely unknown; 
however, a possible scenario is that in its genetic forms, al-
terations of the coagulation cascades could be a cornerstone 
of the disease. Collectively, defects leading to increased 
coagulation can be assimilated to thrombophilia (also 
called hypercoagulopathy, an abnormal increase in the 
propensity of the blood to clot). The coagulation cascade 
is a complex series of biological events that ought to be 
tightly controlled [Figure 2]. At the center of this cascade 
is thrombin (or coagulation factor II, F2), an enzyme able 
to convert fibrinogen into fibrin, the major constituent of 
the blood clot. Prothrombin, the precursor of thrombin, is 
cleaved and thus activated through the action of coagula-
tion factor X (F10). Despite commonalities in coagulation 
disorders between preeclampsia and RSA, specific genetic 
anomalies have rarely been found in common between the 
two disorders,[124] with the possible exception of angiotensin 
converting enzyme (ACE). In this gene, there is a well-doc-
umented insertion/deletion polymorphism (I/D) for which a 
recent meta-analysis concluded that there was a significant 
association of the D allele with recurrent miscarriage.[125] 
In this analysis, 11 studies with 3357 individuals were 
analyzed. It led to the most significant discrepancy (DD vs 
II, homozygote model) and the relative risk was estimated 
at 1.81 (CI: 1.29ă2.66; p = 0.003). ACE D allele was also 
associated with preeclampsia (in a recent study[126]).
Overall, the subject of a genetic basis for recurrent 
pregnancy loss has been strongly associated with throm-
bophilic disorders, with major scientific contributions.[127] 
This early study was probably the first to systematically 
analyze polymorphisms located in FV Leiden (F5), MTHFR, 
F2 (prothrombin), on a limited number of patients (67) and 
controls (232). In this seminal paper from the group of Irene 
Cetin, FVL and prothrombin mutations were found to be 
associated with a triple risk of pregnancy loss. Overall, the 
existence of a thrombophilic state seems a recurrent issue 
in RSA, as reviewed several times.[128-130] Following these 
early discoveries, thrombophilia appeared as a general risk 
Figure 2: A simplified picture of the coagulation cascade. Genes 
that were mainly studied for their putative relation with RSA are 
represented in yellow boxes.
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factor for pregnancy; logically, there have been several 
studies throughout the world, aiming at identifying poly-
morphisms in coagulation cascade factors encoding genes, 
in the context of recurrent miscarriage. Recently, Cao and 
coworkers carried out an extensive analysis of factors known 
to be involved in thrombophilia.[131] They genotyped six 
polymorphisms in SERPINC1 (G786A), THBD (C1418T), 
TFPI (T-33C), FVL (G1628A), F2 (prothrombin, A19911G), 
and ANXA5 (G76A) using mass array spectrometry. This 
screen allowed identifying a significant effect only of 
thrombomodulin (THBD) from 94 cases and 169 controls. 
Interestingly, a large part of the genes studied were common 
to those of another study from Brazil.[132] The latter article 
focused upon 117 RSA and 264 control patients, who were 
analyzed for protein C (PROC), at two SNPs (A2418G and 
C2405T), SERPINC1 (G786A, common to the previous 
study), THBD (C1418T, common to the previous study), 
and TFPI (T-287C, C-399T, and T-33C, common to the 
previous study), FVL (G1691A), and F2 (G20210A); 
therefore, five genes and three SNPs were common to both 
studies. Univariate logistic regression revealed an effect of 
SERPINC1 and TFPI variants only. The P value for THBD 
was estimated at 0.661, and did not even reveal a trend. It 
is interesting to note, however, that the T-33C variant, com-
mon to both studies was not significant in any of them. In 
the study of Cao, SERPINC1 did not display any trend as 
well. Therefore, there are clear discrepancies between the 
two studies for THBD and SERPINC1. Analyzing these 
two situations may, nevertheless, be illustrative of specific 
pitfalls in this type of association studies, the major one 
certainly being the ethnic origin of the patients: Chinese in 
one case, Brazilian and multiethnic in the other. This leads 
to strong discrepancies in the basic allelic frequencies of 
each of the common SNPs in the two studies [Table 1]. In 
this table, the alleles that were significantly different in one 
of the populations are marked in gray. This type of analysis 
demonstrates highly significant discrepancies in the allelic 
frequencies between the two populations, as well as in cases 
and in controls.
Whole genome approaches
In terms of genetic determinism, the novel existing 
tools of genome wide association studies have recently al-
lowed to identify genomic regions putatively encompassing 
genes involved in pregnancy success or pregnancy loss. 
However, so far, only two papers have been published 
dealing with such approaches.[133,134] The premises of 
the latter study were provided by the observation of an 
increased risk of miscarriage in sisters sharing identical 
HLA variants.[58,135] This is consistent with the increased 
risk of recurrent pregnancy loss exhibited by patients ho-
mozygous for the 14-bp insertion in the 8th exon of HLA-G, 
as previously described. The study of 2011 confirmed 
the increased risk of recurrent miscarriage in siblings by 
analyzing 244 patients and 381 full siblings, of whom 
23 had more than two miscarriages and three had two 
siblings with more than two miscarriages. The average 
risk of miscarriage in the control population was almost 
stable (10-15%) between 15 and 32 years of maternal age, 
rising steeply after this age. But at any age, the risk was 
between 1.5- and 2-fold higher in the siblings than in the 
reference population (25.3 vs 13.1%). By a genetic study 
using only 30 small nuclear families and ~60,000 SNPs, 
suggestive linkages on subpopulations could be detected 
for SNPs in the genes FHIT (3p14.2), FAM154A (9p22.1), 
PDE2A (11q13.4), and GRIK2 (6q16.3) [Logarithm of the 
Odds (LOD) scores were between 2.5 and 3]. The other 
genome wide study published in 2010 by Li and coworkers 
identified three regions (6q27, 9q33.1, and Xp22.1) that 
were not the same.[133] In fact, again, the dissimilar origin 
of the population under scrutiny (Han Chinese) can be one 
of the causes of this phenomenon. Also, it was a pilot study 
performed on a very limited number of samples, with me-
dium marker resolution (430 microsatellites). To the best of 
our knowledge, a high-density SNP analysis (with 250,000 
or 500,000 SNPs) has not been performed yet, while such 
an analysis could improve the detection.
Conclusions
As shown before, the genetic study of pregnancy loss fo-
cused overall on a limited number of genes, which have been 
analyzed in numerous human populations. Following these 
observations, two hypotheses can be proposed: either (i) The 
major genes have already been found and duly studied and 
they explain much of the genetic bases of RSA or, on the 
contrary, (ii) this phenotype is so complex that many genes 
Table 1: Rare allele frequencies in two populations studied 
for RPL in the context of coagulation cascades
Cao (2013) 
Chinese
Guerra-Shinohara 
(2012) Brazilian
P value
SERPINC1 (G786A)
Cases 0,298 0,137 5,14 10−5
Controls 0,311 0,087 3,97 10−17
THBD (C1418T)
Cases 0,293 0,132 4,96 10−5
Controls 0,207 0,116 2,4 10−4
TFPI (T-33C)
Cases 0,101 0,35 2,41 10−9
Controls 0,107 0,324 2,55 10−13
The polymorphisms that were significantly different between controls 
and RSA patients are in bold. The P values refer to significant statistical 
differences in allelic frequencies between the two populations assessed 
by a χ2 contingency test, independent of the potential effect in terms 
of pregnancy loss, RPL: Recurrent pregnancy loss, SERPINC1: ???, 
THBD: ???, TFPI: ???
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with small effects can cause the disease, and the systematic 
study of some of them results from a very partial under-
standing of the causes underlying RSA. One such example 
is methylene tetrahydrofolate reductase (MTHFR). This 
enzyme, which is ubiquitously expressed, is responsible for 
the synthesis of 5-methyltetrahydrofolate. This molecule is 
the main methyl donor allowing conversion of homocysteine 
to methionine. In 1997, a Dutch team decided to study the 
677 C→T mutation, shown as a risk factor for coronary 
artery disease in particular.[136] This study, published in The 
Lancet,[137] compared 197 patients who suffered from two or 
more consecutive miscarriages, with 113 matched controls 
and with a larger population of 1250 women. The author con-
cluded that the 677 TT genotype was associated with a ~2-3 
fold increased risk of recurrent miscarriage. Following this 
study, 39 other articles dealing with MTHFR and RPL can 
be found in Pubmed, up to the year 2013, amongst which 
one is a recent meta-analysis,[131] combining 677 C→T with 
another polymorphism (A1298C).  This last work focused 
on 3559 cases and 5097 controls and concluded that the 
T allele had a mod erate negative effect (CT + TT genotypes, 
OR: 1.68, 95% CI: 1.32ă2.13; p < 0.0001), the effect being 
stronger in East Asian populations.
It is interesting to note that almost all the studies attempt-
ed to identify significant variants by genetically analyzing a 
limited range of individuals (almost always less than 300). 
This means that rare variants cannot be found despite a clear 
effect.  An exception to this is the identification of the JAK2 
V617F mutation when a huge sample of 3496 pairs of women 
was analyzed.[138] With such a powerful structure, it was pos-
sible to detect a very significant increased risk of fetal loss but 
with low allelic frequencies of the V617F mutation (1.06% 
in cases vs 0.20% in controls, OR: 4.63, CI: 1.76-12.2). The 
risk was even higher in women with embryonic losses than 
in those with fetal loss. This observed effect of the low fre-
quency of the risk variant could logically be very difficult to 
reproduce in smaller samples, while the biological interest of 
the study remains intact in terms of understanding the patho-
physiology of RSA. Another possible approach to discover 
new genes is to use information gleaned from model spe-
cies, following genome scans. This was recently performed 
in an interspecific recombinant congenic collection of mice 
followed during gestation by ultrasonography,[139] which 
recently allowed to propose human alkaline phosphatase 
polymorphisms to be associated with increased or decreased 
risk of pregnancy loss.[140] In addition, various studies on mice 
demonstrated the importance of several pathways in this 
model species as well; this is the case for the complement 
system and its modulator genes. For instance, mouse models 
have provided a solid base of the importance of complement 
activation in successful pregnancies (C3 being a pivotal 
molecule), as well as its regulation by Crry, sometimes in 
relation with autoimmune diseases.[40,141-145] Therefore, while 
the topic of the present review was human disease, it is clear 
that much can be understood mechanistically using animal 
models, especially rodents.
Different genetic cascade defects can result in pregnancy 
loss [Figure 3]. Very few studies on humans revealed func-
tional insights on the events ending in pregnancy termination. 
Some pieces of this puzzle may definitely be missing today, 
but it would be of great importance to move to more mechanis-
tic models to better understand the genetic bases of abortion.
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